BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Walleye Trading LLC | 15,800 | $111,864 | 0.00% |
| Walleye Trading LLC | 9,956 | $70,488 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 130,800 | $926,064 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 319,617 | $2,262,888 | 0.00% |
| GTS SECURITIES LLC | 15,800 | $111,864 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 714 | $4,787 | 0.00% |
| Financial Gravity Asset Management, Inc. | 2 | $10 | 0.00% |
External links
This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.